Patents Assigned to 1411198 Ontario Limited
  • Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
    Patent number: 7202276
    Abstract: This invention relates to the regulation of vascular endothelium biocompatibility and to the inhibition of vessel wall cell and other types of cell hyperplasia following vessel wall dysfunction and/or injury. More particularly, the invention relates to the dietetic and pharmaceutical preparations of 13-hydroxyoctadeca-9Z, 11E-dienoic acid (13-HODE) and its use in reducing or inhibiting vessel wall hyperlasia and restoring vessel wall biocompatibility.
    Type: Grant
    Filed: April 9, 2001
    Date of Patent: April 10, 2007
    Assignee: 1411198 Ontario Limited
    Inventors: Michael Buchanan, David Horrobin